Bp PLC Abbott Laboratories Transaction History

Bp PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $20.7 Million - $22.9 Million	-177,110 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $24.5 Million - $28.9 Million	-231,695 Reduced 56.68%	177,110 $20.5 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $6.3 Million - $7.43 Million	57,916 Added 16.51%	408,805 $49 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $11.1 Million - $12.1 Million	-105,887 Reduced 23.18%	350,889 $38.4 Million
Q3 2020 Oct 30, 2020	BUY	$91.64 - $111.29 $26.5 Million - $32.2 Million	289,476 Added 173.03%	456,776 $49.7 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $474,733 - $607,600	-6,200 Reduced 3.57%	167,300 $15.3 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $31,410 - $45,930	-500 Reduced 0.29%	173,500 $13.7 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $327,360 - $354,960	-4,000 Reduced 2.25%	174,000 $14.6 Million
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $2.62 Million - $2.97 Million	-40,000 Reduced 18.35%	178,000 $12.9 Million
Q3 2018 Nov 02, 2018	BUY	$60.81 - $73.36 $274,982 - $331,733	4,522 Added 2.12%	218,000 $16 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $10.3 Million - $11.5 Million	213,478	213,478 $11.4 Million

3,164

1.33B

8.63M

7.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.